You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

429 Results
Drug
Other Name(s): Xpovio®
Mar 2024
Guidelines and Advice
Status: Current
ID: GL 19-7
Mar 2024
This is FR page
The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Curative
Funding:
ODB - General Benefit
    filgrastim (biosimilars) - refer to ODB Formulary for details
Nov 2025

Pages